Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Gait Mechanics are Different between Healthy Controls and Patients with Multiple Sclerosis.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
No Differences Observed among Multiple Clinical S1P1 Receptor Agonists (Functional Antagonists) in S1P1 Receptor Down-regulation and Degradation.
Safety Study of Interferon Beta-1a for Acute Stroke
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
LC-MS/MS determination of FTY720 and FTY720-phosphate in murine intracellular compartments and human plasma.
Glatiramer Acetate and Nanny Proteins Restrict Access of the Multiple Sclerosis Autoantigen Myelin Basic Protein to the 26S Proteasome.
Mechanism-based CNS Disease Modeling: Applications in Neurology and Psychiatry Drug Research & Development
The immunopathology of multiple sclerosis: an overview.
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
Gordon Research Conference on Immunochemistry & Immunobiology
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
Teva and Active Biotech to continue with the development of NERVENTRA® (laquinimod) for multiple sclerosis following confirmation of CHMP opinion
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath.
Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.
New insights into signaling during myelination in zebrafish.

Pages